Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.
Lexington father of two, Eric Green, has been waiting for this moment for months. He recently learned his 10-year-old son Vincent could get the COVID-19 vaccine soon.